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Purpose: To investigate the genetic basis of autosomal recessive retinal degeneration in a large consanguineous family
from Pakistan.
Methods: Ophthalmic examinations were conducted on family members to establish their diagnosis. Genomic DNA
extracted from peripheral blood was used for homozygosity mapping to discover the chromosomal region that harbors
the defective gene. Direct sequence analysis and restriction enzyme digestion were used to identify and confirm the defect
in the gene.
Results: There were three affected siblings in the family, each with limited peripheral vision and impaired visual acuity.
We established linkage to a region on chromosome 2 that encompasses the RP26 locus. Upon sequencing the ceramide
kinase-like (CERKL) gene, which is mutated in the original RP26 family, we identified a C>A transversion in exon 2 (c.
316C>A) that substitutes an arginine residue with a serine (p.R106S) in the conserved nuclear localization signal sequence
(KLKRR) of the protein. This mutation segregated with retinal degeneration in the Pakistani family and was not observed
in the DNA of 174 ethnically matched unaffected controls.
Conclusions: This is the third reported mutation in CERKL causing retinal degeneration but is the first report to show
that a single amino acid change in CERKL, rather than a null mutation, can cause retinal disease. Although the function
of CERKL is still unknown, the mutation described herein confirms that the nuclear localization signal sequence is
important in the physiologic function of the protein.
Retinal degenerations are a heterogeneous group of eye
disorders (see RetNet), which together cause a significant
proportion  of  human  blindness.  A  common  feature  is
photoreceptor  cell  death,  with  conditions  such  as  retinitis
pigmentosa predominantly affecting the rod while cone and
macular dystrophies lead to cone degeneration. Sometimes
both rods and cones are involved, with the degeneration of one
preceding  the  other.  The  patient’s  symptoms  can  often
highlight which photoreceptors are involved—for example,
rod degeneration presents as night blindness or visual field
constriction, while defective color vision, photophobia, or
reduced visual acuity signifies a deficiency in cone function.
Often  a  measurement  of  electroretinogram  responses  to
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different light intensities or colors can also assist in evaluating
the primary cellular defect [1,2].
Many of the disorders that lead to retinal degeneration
have a genetic basis and can be inherited in an autosomal-
recessive,  autosomal-dominant,  or  X-linked,  as  well  as
mitochondrial  and  polygenic  manner  [3-5].  There  is  also
considerable genetic heterogeneity; for example, mutations in
21 genes have thus far been identified as causing autosomal
recessive retinitis pigmentosa (RetNet). Recent efforts have
focused on designing assays to assist in the rapid genetic
diagnosis of retinal disease in affected individuals, as well as
carriers, so as to provide genetic counseling for the patients
and their families [6-8].
Here we describe a consanguineous family from Pakistan
with 3 siblings who have retinal degeneration. A genome-
wide screen for homozygosity was performed, and a region at
the RP26 locus [9] was found to cosegregate with the disease
phenotype.  A  novel  mutation  in  the  ceramide  kinase-like
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1960(CERKL) gene was identified. This is the third report of a
mutation in the CERKL gene causing autosomal recessive
retinal degeneration.
METHODS
Patients  and  controls:  The  study  of  human  subjects  was
performed according to the principles of the Declaration of
Helsinki using a process approved by a UK ethics committee.
The  proband  was  one  of  three  affected  siblings  with
deteriorating vision who were part of a large consanguineous
family from Lahore in Pakistan (see Figure 1). After obtaining
informed  consent  from  the  elder  of  each  household,  we
conducted an ophthalmic examination and took a sample of
peripheral blood from the family members. Genomic DNA
was extracted from the blood using the QIAamp DNA Blood
Midi  Kit  (Qiagen,  Crawley,  UK)  according  to  the
manufacturer’s instructions. Control subjects were unrelated
normal individuals who were recruited as siblings of patients
subject to genetic testing by the Yorkshire Regional Genetics
screening service at St. James’s Hospital, Leeds. None of the
families  involved  had  any  member  with  an  inherited  eye
abnormality  and  all  the  individuals  were  of  Asian
subcontinent extraction.
Homozygosity mapping: Aliquots of DNA from affected and
unaffected  family  members  were  genotyped  for  over  400
markers covering all human chromosomes by the Marshfield
Institute.  Candidate  homozygous  regions  were  further
analyzed  with  additional  markers  that  intersected  the
Marshfield data set using fluorescently labeled primers. The
products were mixed with the size standard GeneScan 500-
ROX (Applied Biosystems, Warrington, UK) and resolved by
electrophoresis  on  a  3130xl  Genetic  Analyzer  (Applied
Biosystems).  The  results  were  analyzed  using  the
GeneMapper  version  4.0  software  (Applied  Biosystems).
Pedigree and haplotype data were managed with the Cyrillic
package  version  2.1.  A  multipoint  linkage  analysis  was
performed  using  the  LinkMap  from  the  Linkage  suite  of
programs [10].
DNA sequencing: Specific primer pairs encompassing the 14
coding exons, as well as the intron-exon boundaries, of the
CERKL gene have been described before [11]. These were
used (Table 1) in the PCR to amplify products that were
initially digested with ExoSAP-IT (GE Healthcare, Chalfont
St. Giles, UK) according to the supplier’s instructions. The
digested  DNA  was  sequenced  directly  using  the  BigDye
Terminator version 3.1 Cycle Sequencing Kit and the 3130xl
Genetic  Analyzer  according  to  the  manufacturer’s
instructions (Applied Biosystems).
Mutation restriction analysis: To screen for the c.316C>A
mutation in additional family members and control DNAs, we
performed PCR. We employed a forward primer that had been
designed with a deliberate mismatch at the fourth residue from
the 3-prime end (underlined; C instead of an A nucleotide:
dAAA GAC ATA TTC TCT GTG AAA CTG AAC CGG)
and a reverse primer (dCCA TAT GTC ACA GTG GTC
Figure 1. Pedigree structure. Pedigree of the Pakistani family shows
affected members (shaded) who have retinal degeneration and those
individuals who are unaffected (unshaded). The arrow marks the
proband. The numbers mark the family members from whom DNA
is available.
TABLE 1. OLIGONUCLEOTIDE PRIMER PAIRS USED FOR THE AMPLIFICATION OF CERKL EXONS.
Exon Primer sequence (F) Primer sequence (R)
Product size
(bp)
1 dACTTTACAGGAGAAGCTAGGCG dCTTGTGACGTTTGCCCGG 787
2 dCCATCTCACGTAGGGACTGG dTATACACCATGGCCATTGGG 900
3 dCTAACAGACTTGTGTGTC dCCCAAGTTTGCATTAAGGAC 305
4 dGCCAGAACAAGTTAAAAAGTGTG dTGTAGCTAAAACTAGTGAAGGCA 209
4a dGTCTGTGATAGATTGAGGGAAGA dCACATCAGTCCAACACTTTAGC 280
5 dGGTACATGTGAGCAGTTATGCAC dTAGTGGGGATGCCAGAAGTC 399
6 dCATCTGAACATTGAAGAATGAC dGAGACAAAGAACCTGCCTTT 283
7+8 dGCTCTCTTATGTTTGCTG dCTGATCAATTGTTTGTCAGAATG 460
9+10 dCCTACTGTGATGACAAATCCC dGGCAGCAACAAAATTGTACG 548
11 dCATGGTGATTTATCTATCTTGTCCA dCAATTCTTGCAGCATCTTTTTC 299
12 dCTTGTGAGAGAGGGCTCAGTG dCCAACTGCCTGCTTTGATAGTTC 358
13 dGGCATTGGCATTGTGTACC dCTGAGGTGGAACAGTTCATCC 308
The expected size of each amplified product is depicted.
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1961TTC), and we used an annealing temperature of 58 °C. The
PCR product containing the wildtype and/or mutant sequence
was  digested  with  the  restriction  endonuclease  BsaWI
(W↓CCGGW) (New England Biolabs, Hitchen, UK). After
incubation  at  60  °C,  the  reaction  products  were  resolved
through a 2% agarose gel by electrophoresis. For wildtype
sequence, a single band of 168 bp would be expected, however
for a mutant sequence the product would be digested to yield
140 and 28 bp.
Bioinformatics: Comparative genomics for protein sequence
conservation  across  mammalian  and  non-mammalian
vertebrates  were  investigated  using  the  University  of
California Santa Cruz Genome Browser, which is maintained
by the Genome Bioinformatics Group there. This study used
the Vertebrate Multiz Alignment and PhastCons Conservation
package.
RESULTS
We evaluated autosomal recessive retinal degeneration in a
Pakistani family that included three brothers with poor vision.
The parents are first cousins and are unaffected, suggesting
that the visual deficit is due to a mutation transmitted from a
common ancestor as an autosomal recessive trait. The three
affected brothers were examined at 29, 36, and 42 years of
age. All reported nyctalopia and loss of visual field from early
in the second decade, followed by loss of visual acuity, often
with photophobia, from the end of the second or early in the
third decade. At the time of examination, acuity was limited
Figure 2. Sequence analysis of the CERKL gene. The sequencing
chromatograms show the forward strand of CERKL exon 2 from a
normal  control  and  the  affected  proband.  Depicted  is  a  single
nucleotide change C>A (shown by the arrow) in the DNA of the
affected proband, which creates a missense change in the protein
sequence replacing an arginine (Arg) with a serine (Ser) residue.
to perception of light only in two brothers and no perception
of  light  in  one  brother.  Two  brothers  had  roving  eye
movements. Mean refractive error was −3.8 diopters. The eyes
of  the  affected  individuals,  all  had  posterior  subcapsular
cataract, except for one which was pseudophakic. Disc pallor
and arterial attenuation were universal findings. Bone spicule
pigmentation was seen anterior and posterior to the equator in
all eyes, with white dots in the outer retina anterior to the
temporal vascular arcades. Despite the visual acuity, the only
macular abnormality was cellophane maculopathy in 5 of 6
eyes. As the patients were seen in Pakistan, it was not possible
to obtain electroretinograms or fundus photographs.
To  identify  the  defective  gene  causing  retinal
degeneration  in  this  family,  we  sent  genomic  DNA  from
affected  individuals  and  their  relatives  to  the  Marshfield
Institute Mammalian Genotyping Service, Marshfield, WI for
homozygosity  mapping.  This  highlighted  a  region  of
Figure 3. Analysis of the c.316C>A mutation. Ultraviolet illuminated
agarose gel presents BsaWI-digested PCR products from the DNA
of each of the family members. A band size of 168 bp represents an
uncut digest that would exist in the presence of a wildtype sequence.
The presence of a digested 140 bp band occurs when a mutant
sequence is present. The 28 bp band following digestion of the
mutant sequence cannot be seen as it has run off the gel. Note the
segregation of the mutation with the disease phenotype so that only
the DNA from the affected individuals gives rise to a single 140 bp
band after digestion of the PCR.
Figure 4. Protein sequence conservation. Diagram shows part of the
amino acid sequence of the CERKL protein from multiple species
around the nuclear localization signal sequence (NLS), which is
represented as “KLKRR” in humans. Note the asterisk (*), which
marks the evolutionary conserved arginine (R) residue in the normal
sequence that is mutated to a serine in patients who go on to develop
retinal degeneration.
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1962homozygosity on chromosome 2 at the RP26 locus, previously
implicated in recessive RP. We therefore screened the DNA
of one of the affected brothers (the proband) and a normal
control individual for the 14 coding exons and splice site
junctions of CERKL, the gene implicated in the RP26 form of
inherited blindness. Following direct sequence analysis, we
identified  a  C>A  transversion  in  exon  2  (c.316C>A)  that
substitutes an arginine residue with a serine (p.R106S) in the
protein  sequence  (Figure  2).  This  was  the  only  sequence
variant identified during the analysis. This single base change
segregates with the disease phenotype (Figure 1 and Figure 3)
and was excluded from the DNA of 174 ethnically matched
unaffected individuals.
The  arginine  at  position  156  in  CERKL  is  highly
conserved among other species (Figure 4). The mutation is
likely  to  disrupt  the  nuclear  localization  signal  sequence
“KLKRR”  that  is  necessary  for  targeting  CERKL  to  the
nucleus and for enriching the protein in the nucleolus [12]. A
serine residue at position 156 is therefore highly likely to be
pathogenic and would be expected to account for the retinal
degeneration seen in this family.
DISCUSSION
In this paper we report the identification of a novel mutation
in the CERKL gene (c.316C>A, p.R106S) that causes retinal
degeneration in a large consanguineous family from Pakistan
with 3 affected siblings. This is the third reported case of
CERKL gene mutations causing retinal disease and the first
presenting  a  missense  mutation,  rather  than  a  null  allele.
Previous  reports  have  identified  a  premature  stop  codon
mutation as the cause of disease in the original RP26 family
from Spain as well as several other families of Spanish origin
(p.R257X) [13,14]. Auslender et al. reported a mutation in a
splice  site  signal  that  destroyed  the  splice  recognition
sequence as a founder mutation that caused retinal disease in
a  Yeminite  Jewish  population  (c.238+1G>A)  [11].
Examinations  performed  on  the  affected  individuals  from
these three studies as well as this study have highlighted
similar  clinical  features,  involving  both  rod  and  cone
degeneration, the presence of retinal pigmentary deposits and
macular alterations leading to a deficit in both peripheral and
central vision.
The function of CERKL in the human retina is unknown.
CERKL transcripts have been shown to be expressed in the
ganglion  and  photoreceptor  layers  of  the  retina  [13],  and
generally show a restrictive pattern of expression in tissues,
compared  to  the  homolog,  CERK,  which  is  ubiquitously
expressed [13,15]. CERKL has a kinase motif as well as a
putative Ca2+/calmodulin binding domain at the C-terminal
end [15]. However, the activity of CERKL is still unknown,
unlike CERK, which phosphorylates ceramide to ceramide-1-
phosphate [16]. Nevertheless, clues to CERKL regulation and
function  come  from  the  observation  that  it  can  be
phosphorylated [15] and also that it localizes to the nucleolus
[12,15].  The  former  requires  further  investigation  but  the
latter has been investigated. Subcellular localization studies
following overexpression of tagged CERKL into transfected
cells  have  highlighted  its  distribution  in  the  cytoplasm,
nucleus, and in particular its enrichment in the nucleolus (15).
CERKL  possesses  a  nuclear  localization  signal  sequence
(102-KLKRR-106)  that  permits  the  active  transport  of
CERKL from the cytoplasm into the nucleus [12]. A single
amino  acid  substitution,  which  disrupts  the  nuclear
localization signal (p.R105A), prevents the mutant CERKL
from localizing to the nucleus [12], as does the splice site
variant,  del1–205,  which  lacks  the  nuclear  localization
sequence altogether [15]. Interestingly, the CERKL mutants,
p.R257X, p.R379X, and p.G234D, which contain the nuclear
localization sequence, are indeed transported into the nucleus
but do not localize to the nucleolus, suggesting that other
features of CERKL contribute to the nucleolar localization
[15].  Treatment  with  a  calcium  ionophore  also  prevents
localization of wildtype CERKL to the nucleolus [15]. It is
noteworthy  that  the  missense  mutation  identified  in  the
Pakistani family reported in this paper (p.R106S) would be
expected to disrupt the nuclear localization signal sequence.
Thus the mechanism for triggering retinal degeneration in
these patients could be the absence of nuclear localization and
subsequent accumulation of mutant CERKL in the cytoplasm,
which might be expected to trigger apoptotic cell death.
The  wildtype  proteins  corresponding  to  other  ‘retinal
degeneration’ genes have also been shown to localize to the
nucleolus. These include the oxygen-regulated photoreceptor
protein (ORP1) and tubby-like protein 1 (TULP1) [17,18],
and mutations in the corresponding genes have been shown to
cause RP1 and RP14 [19,20]. The nucleolus, which contains
rRNA  genes  and  the  factors  for  ribosome  and
ribonucleoprotein particle biosynthesis, is a multifunctional
organelle that is now thought to be involved in the regulation
of mitosis, cell cycle progression and many forms of stress
response [21]. CERKL may have an important role in any of
these processes in the cells of the retina and the functional link
between  CERKL  and  it’s  nucleolar  localization  warrants
further study.
ACKNOWLEDGMENTS
We  thank  Dr.  Helen  Lindsay  from  Yorkshire  Regional
Genetics at St. James’s University Hospital for providing a
panel of control DNAs. We acknowledge the MRC (Grant
G0501050),  the  Wellcome  Trust  (Grant  073477),  and  the
Yorkshire Eye Research (Grant 009) for providing financial
support.
REFERENCES
1. Andreasson  S.  Development  in  molecular  genetics  and
electrophysiology  in  inherited  retinal  disorders.  Acta
Ophthalmol Scand 2006; 84:161-8. [PMID: 16637830]
2. Audo I, Robson AG, Holder GE, Moore AT. The negative ERG:
clinical phenotypes and disease mechanisms of inner retinal
Molecular Vision 2008; 14:1960-1964 <http://www.molvis.org/molvis/v14/a231> © 2008 Molecular Vision
1963dysfunction.  Surv  Ophthalmol  2008;  53:16-40.  [PMID:
18191655]
3. Rivolta  C,  Sharon  D,  DeAngelis  MM,  Dryja  TP.  Retinitis
pigmentosa and allied diseases: numerous diseases, genes,
and inheritance pattern. Hum Mol Genet 2002; 11:1219-27.
[PMID: 12015282]
4. Hims MM, Diager SP, Inglehearn CF. Retinitis pigmentosa:
genes,  proteins  and  prospects.  Dev  Ophthalmol  2003;
37:109-25. [PMID: 12876833]
5. Kennan  A,  Aherne  A,  Humphries  P.  Light  in  retinitis
pigmentosa.  Trends  Genet  2005;  21:103-10.  [PMID:
15661356]
6. Kondo H, Qin M, Mizota A, Kondo M, Hayashi H, Hayashi K,
Oshima  K,  Tahira  T.  A  homozygosity-based  search  for
mutations  in  patients  with  autosomal  recessive  retinitis
pigmentosa, using microsatellite markers. Invest Ophthalmol
Vis Sci 2004; 45:4433-9. [PMID: 15557452]
7. Zernant J, Kulm M, Dharmaraj S, den Hollander AI, Perrault I,
Preising MN, Lorenz B, Kaplan J, Cremers FP, Maumenee I,
Koenekoop  RK,  Allikmets  R.  Genotyping  microarray
(disease chip) for Leber congenital amaurosis: detection of
modifier  alleles.  Invest  Ophthalmol  Vis  Sci  2005;
46:3052-9. [PMID: 16123401]
8. Pomares E, Marfany G, Brion MJ, Carracedo A, Gonzalez-
Duarte  R.  Novel  high-throughput  SNP  genotyping
cosegregation analysis for genetic diagnosis of autosomal
recessive retinitis pigmentosa and leber congenital amaurosis.
Hum Mutat 2007; 28:511-6. [PMID: 17279538]
9. Bayes M, Goldaracena B, Martinez-Mir A, Iragui-Madoz MI,
Solans T, Chivalet P, Bussaglia E, Ramos-Arroyo MA, Baiget
M, Vilageliu L, Balcells S, Gonzalez-Duarte R, Grinberg D.
A new autosomal recessive retinitis pigmentosa locus maps
on  chromosome  2q31-q33.  J  Med  Genet  1998;  35:141-5.
[PMID: 9507394]
10. Lathrop GM, Lalouel JM. Easy calculations of lod scores and
genetic risks on small computers. Am J Hum Genet 1984;
36:460-5. [PMID: 6585139]
11. Auslender N, Sharon D, Abbasi AH, Garzozi HJ, Banin E, Ben-
Yosef T. A common founder mutation of CERKL underlies
autosomal recessive retinal degeneration with early macular
involvement among Yemenite Jews. Invest Ophthalmol Vis
Sci 2007; 48:5431-8. [PMID: 18055789]
12. Inagaki Y, Mitsutake S, Igarashi Y. Identification of a nuclear
localization signal in the retinitis pigmentosa-mutated RP26
protein, ceramide kinase-like protein. Biochem Biophys Res
Commun 2006; 343:982-7. [PMID: 16581028]
13. Tuson  M,  Marfany  G,  Gonzalez-Duarte  R.  Mutation  of
CERKL,  a  novel  human  ceramide  kinase  gene,  causes
autosomal recessive retinitis pigmentosa (RP26). Am J Hum
Genet 2004; 74:128-38. [PMID: 14681825]
14. Avila-Fernandez A, Riveiro-Alvarez R, Vallespin E, Wilke R,
Tapias I, Cantalapiedra D, Aguirre-Lamban J, Gimenez A,
Trujillo-Tiebas  M-J,  Ayuso  C.  CERKL  mutations  and
associated  phenotypes  in  seven  Spanish  families  with
autosomal recessive retinitis pigmentosa. Invest Ophthalmol
Vis Sci 2008; 49:2709-13. [PMID: 18515597]
15. Bornancin F, Mechtcheriakova D, Stora S, Graf C, Wlachos A,
Dévay P, Urtz N, Baumruker T, Billich A. Characterization
of a ceramide kinase-like protein. Biochim Biophys Acta
2005; 1687:31-43. [PMID: 15708351]
16. Sugiura M, Kono K, Liu H, Shimizugawa T, Minekura H,
Spiegel S, Kohama T. Ceramide kinase, a novel lipid kinase.
Molecular  cloning  and  functional  characterization.  J  Biol
Chem 2002; 277:23294-300. [PMID: 11956206]
17. He W, Ikeda S, Bronson RT, Yan G, Nishina PM, North MA,
Naggert  JK.  GFP-tagged  expression  and
immunohistochemical studies to determine the subcellular
localization of the tubby gene family members. Brain Res Mol
Brain Res 2000; 81:109-17. [PMID: 11000483]
18. Andersen JS, Lyon CE, Fox AH, Leung AKL, Lam YW, Steen
H, Mann M, Lamond AI. Directed proteomic analysis of the
human  nucleolus.  Curr  Biol  2002;  12:1-11.  [PMID:
11790298]
19. Sullivan LS, Heckenlively JR, Bowne SJ, Zuo J, Hide WA, Gal
A,  Denton  M,  Inglehearn  CF,  Blanton  SH,  Diager  SP.
Mutations in a novel retina-specific gene cause autosomal
dominant retinitis pigmentosa. Nat Genet 1999; 22:255-9.
[PMID: 10391212]
20. Gu S, Lennon A, Li Y, Lorenz B, Fossarello M, North M, Gal
A, Wright A. Tubby-like protein-1 mutations in autosomal
recessive  retinitis  pigmentosa.  Lancet  1998;  351:1103-4.
[PMID: 9660588]
21. Boisvert F-M, van Koningsbruggen S, Navascues J, Lamond
AI. The multifunctional nucleolus. Nat Rev Mol Cell Biol
2007; 8:574-85. [PMID: 17519961]
Molecular Vision 2008; 14:1960-1964 <http://www.molvis.org/molvis/v14/a231> © 2008 Molecular Vision
The print version of this article was created on 24 October 2008. This reflects all typographical corrections and errata to the
article through that date. Details of any changes may be found in the online version of the article.
1964